Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Oncologist
; 28(10): 875-884, 2023 10 03.
Article
in En
| MEDLINE
| ID: mdl-37676712
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuroendocrine Tumors
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
Turkey